{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:10:25Z","timestamp":1790205025089,"version":"4.1.0"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejphar.2023.176047","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T12:39:06Z","timestamp":1695386346000},"page":"176047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The therapeutic potential of resolvins in pulmonary diseases"],"prefix":"10.1016","volume":"958","author":[{"given":"Daniel","family":"Centanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.J.","family":"Henricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdi","family":"Engels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.176047_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12016-019-08754-9","article-title":"Resolvins: emerging players in autoimmune and inflammatory diseases","volume":"58","author":"Abdolmaleki","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2022.875047","article-title":"Resolvin E1's antimicrobial potential against Aggregatibacter actinomycetemcomitans","volume":"3","author":"Abdullatif","year":"2022","journal-title":"Front. Oral Health"},{"key":"10.1016\/j.ejphar.2023.176047_bib3","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100540R","article-title":"High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients","volume":"35","author":"Archambault","year":"2021","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2023.176047_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib5","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.178.6.3912","article-title":"Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation","volume":"178","author":"Arita","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib6","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.4049\/jimmunol.1502268","article-title":"Resolvin D3 Is dysregulated in arthritis and reduces arthritic inflammation","volume":"197","author":"Arnardottir","year":"2016","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.ejphar.2023.176047_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jpain.2022.12.013","article-title":"Sex dimorphism in resolvin D5-induced analgesia in rat models of trigeminal pain","volume":"24","author":"Baggio","year":"2023","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2023.176047_bib8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1476-5381.2010.00909.x","article-title":"Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception","volume":"161","author":"Bang","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176047_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pharmthera.2018.01.004","article-title":"Towards targeting resolution pathways of airway inflammation in asthma","volume":"186","author":"Barnig","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2023.176047_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13075-019-1852-8","article-title":"In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis","volume":"21","author":"Benabdoun","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2023.176047_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.actbio.2021.11.047","article-title":"The utilisation of resolvins in medicine and tissue engineering","volume":"140","author":"Blaudez","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejphar.2023.176047_bib12","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fphar.2020.01290","article-title":"The role of specialized pro-resolving mediators in cystic fibrosis airways disease","volume":"11","author":"Briottet","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176047_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.668760","article-title":"Resolvin D1 improves the Treg\/Th17 imbalance in systemic lupus erythematosus through miR-30e-5p","volume":"12","author":"Cheng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib14","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.2018886317","article-title":"Resolvin D4 attenuates the severity of pathological thrombosis in mice","volume":"134","author":"Cherpokova","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.176047_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ejphar.2023.176047_bib16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.176047_bib17","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20150225","article-title":"Identification of resolvin D2 receptor mediating resolution of infections and organ protection","volume":"212","author":"Chiang","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4049\/jimmunol.1601650","article-title":"Novel resolvin D2 receptor axis in infectious inflammation","volume":"198","author":"Chiang","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib19","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood.2021013422","article-title":"Resolvin T-series reduce neutrophil extracellular traps","volume":"139","author":"Chiang","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.176047_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7483","article-title":"Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses","volume":"8","author":"Chiurchiu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2020.09.008","article-title":"Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis","volume":"20","author":"Chmiel","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejphar.2023.176047_bib22","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/S0140-6736(22)00470-6","article-title":"Chronic obstructive pulmonary disease","volume":"399","author":"Christenson","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2023.176047_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/mi.2017.36","article-title":"Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection","volume":"11","author":"Codagnone","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib24","doi-asserted-by":"crossref","first-page":"L888","DOI":"10.1152\/ajplung.00125.2015","article-title":"Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages","volume":"309","author":"Croasdell","year":"2015","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2023.176047_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.chembiol.2012.11.010","article-title":"Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents","volume":"20","author":"Dalli","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejphar.2023.176047_bib26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nm.3911","article-title":"Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections","volume":"21","author":"Dalli","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ijnp\/pyx023","article-title":"Resolvin D1 and D2 reverse lipopolysaccharide-induced depression-like behaviors through the mTORC1 signaling pathway","volume":"20","author":"Deyama","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2023.176047_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jphs.2018.09.006","article-title":"Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice","volume":"138","author":"Deyama","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2023.176047_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00213-017-4774-7","article-title":"Resolvin E1\/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23","volume":"235","author":"Deyama","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2023.176047_bib30","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1038\/s41467-021-26516-0","article-title":"Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy","volume":"12","author":"Dort","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2023.176047_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171249","article-title":"Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis","volume":"12","author":"Eickmeier","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176047_bib32","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3390\/molecules27051677","article-title":"Resolvins, protectins, and maresins: DHA-derived specialized pro-resolving mediators, biosynthetic pathways, synthetic approaches, and their role in inflammation","volume":"27","author":"Ferreira","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2023.176047_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI131609","article-title":"GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections","volume":"130","author":"Flak","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.176047_bib34","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2023.176047_bib35","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1804000116","article-title":"Aspirin-triggered proresolving mediators stimulate resolution in cancer","volume":"116","author":"Gilligan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.176047_bib36","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bph.14587","article-title":"Lipid mediators in immune regulation and resolution","volume":"176","author":"Gilroy","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176047_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1753425916628618","article-title":"Resolvin D1, resolvin D2 and maresin 1 activate the GSK3beta anti-inflammatory axis in TLR4-engaged human monocytes","volume":"22","author":"Gu","year":"2016","journal-title":"Innate Immun."},{"key":"10.1016\/j.ejphar.2023.176047_bib39","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.cell.2021.04.019","article-title":"The basic immunology of asthma","volume":"184","author":"Hammad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2023.176047_bib40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1096\/fj.05-4724fje","article-title":"RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis","volume":"20","author":"Hasturk","year":"2006","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2023.176047_bib41","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ni.1627","article-title":"Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation","volume":"9","author":"Haworth","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib42","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.4049\/jimmunol.1004007","article-title":"NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation","volume":"186","author":"Haworth","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib43","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1096\/fj.10-178657","article-title":"Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice","volume":"25","author":"Hellmann","year":"2011","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2023.176047_bib44","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-121-9-199411010-00010","article-title":"The role of leukotrienes in inflammation","volume":"121","author":"Henderson","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib45","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.4049\/jimmunol.1402166","article-title":"ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages","volume":"194","author":"Herova","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib46","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/IAI.02444-14","article-title":"Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes","volume":"83","author":"Herrera","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejphar.2023.176047_bib47","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.2147\/DDDT.S112389","article-title":"Resolvins and aliamides: lipid autacoids in ophthalmology - what promise do they hold?","volume":"10","author":"Hesselink","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2023.176047_bib48","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.21037\/jtd.2017.10.116","article-title":"Are specialized pro-resolving mediators promising therapeutic agents for severe bronchial asthma?","volume":"9","author":"Hisada","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.ejphar.2023.176047_bib49","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib50","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.176047_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058258","article-title":"A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation","volume":"8","author":"Hsiao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176047_bib52","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/j.ajpath.2015.08.008","article-title":"Resolvin D1 reduces emphysema and chronic inflammation","volume":"185","author":"Hsiao","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2023.176047_bib53","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1074\/jbc.M112.340612","article-title":"Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid","volume":"287","author":"Isobe","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.176047_bib54","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fimmu.2012.00270","article-title":"Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation","volume":"3","author":"Isobe","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib55","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3389\/fimmu.2020.00581","article-title":"Resolvin D1 reduces lung infection and inflammation activating resolution in cystic fibrosis","volume":"11","author":"Isopi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib56","series-title":"Lung Metastasis","author":"Jamil","year":"2022"},{"key":"10.1016\/j.ejphar.2023.176047_bib57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2015.04.003","article-title":"Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function","volume":"84","author":"Kain","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2023.176047_bib58","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.bbalip.2016.06.002","article-title":"Resolvin D1 protects the liver from ischemia\/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis","volume":"1861","author":"Kang","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2023.176047_bib59","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.ajpath.2022.07.004","article-title":"Resolvin E1 reduces tumor growth in a xenograft model of lung cancer","volume":"192","author":"Kantarci","year":"2022","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2023.176047_bib60","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ni1056","article-title":"Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway","volume":"5","author":"Karp","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2020.106479","article-title":"Intrathecal administration of Resolvin D1 and E1 decreases hyperalgesia in mice with bone cancer pain: involvement of endocannabinoid signaling","volume":"151","author":"Khasabova","year":"2020","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.ejphar.2023.176047_bib62","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.3892\/etm.2017.4787","article-title":"Pilot application of lipoxin A(4) analog and lipoxin A(4) receptor agonist in asthmatic children with acute episodes","volume":"14","author":"Kong","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib63","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.0907342107","article-title":"Resolvin D1 binds human phagocytes with evidence for proresolving receptors","volume":"107","author":"Krishnamoorthy","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.176047_bib64","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ajpath.2012.01.028","article-title":"Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs","volume":"180","author":"Krishnamoorthy","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2023.176047_bib65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3892\/or.2015.4389","article-title":"Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-\u03baB activity","volume":"35","author":"Kuang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2023.176047_bib66","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biocel.2013.09.018","article-title":"Resolvin D1 inhibits TGF-beta1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor\/formyl peptide receptor 2 and GPR32","volume":"45","author":"Lee","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.176047_bib67","doi-asserted-by":"crossref","first-page":"12111","DOI":"10.7150\/thno.52135","article-title":"Resolvin D3 controls mouse and human TRPV1-positive neurons and preclinical progression of psoriasis","volume":"10","author":"Lee","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2023.176047_bib68","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fimmu.2012.00390","article-title":"Resolvin D1 and resolvin E1 promote the resolution of allergic airway inflammation via shared and distinct molecular counter-regulatory pathways","volume":"3","author":"Levy","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib69","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1742-2094-11-72","article-title":"Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells","volume":"11","author":"Li","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2023.176047_bib70","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fphar.2020.00612","article-title":"Role of resolvins in the inflammatory resolution of neurological diseases","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176047_bib71","article-title":"A new E-series resolvin: RvE4 stereochemistry and function in efferocytosis of inflammation-resolution","volume":"11","author":"Libreros","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib72","article-title":"Roles of resolvins in chronic inflammatory response","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.176047_bib73","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fphar.2019.00745","article-title":"Resolvin D5 inhibits neuropathic and inflammatory pain in male but not female mice: distinct actions of D-series resolvins in chemotherapy-induced peripheral neuropathy","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176047_bib74","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/SHK.0000000000001865","article-title":"Pro-resolving mediator resolvin E1 restores alveolar fluid clearance in acute respiratory distress syndrome","volume":"57","author":"Luo","year":"2022","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2023.176047_bib75","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13393","article-title":"Metabolipidomic profiling reveals an age-related deficiency of skeletal muscle pro-resolving mediators that contributes to maladaptive tissue remodeling","volume":"20","author":"Markworth","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejphar.2023.176047_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043545","article-title":"Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation","volume":"7","author":"Martin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176047_bib77","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13046-021-01937-3","article-title":"Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes","volume":"40","author":"Mattoscio","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2023.176047_bib78","article-title":"Recent advances in inhalable liposomes for treatment of pulmonary diseases: concept to clinical stance","volume":"56","author":"Mehta","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejphar.2023.176047_bib79","doi-asserted-by":"crossref","DOI":"10.1142\/S1793984417500027","article-title":"Pro-resolution potency of resolvins D1, D2 and E1 on neutrophil migration and in dermal wound healing","volume":"7","author":"Menon","year":"2017","journal-title":"Nano Life"},{"key":"10.1016\/j.ejphar.2023.176047_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174527","article-title":"Resolvin D1, therapeutic target in acute respiratory distress syndrome","volume":"911","author":"Molaei","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176047_bib81","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/cpt.980","article-title":"Potent anti-inflammatory and pro-resolving effects of anabasum in a human model of self-resolving acute inflammation","volume":"104","author":"Motwani","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2023.176047_bib82","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94463","article-title":"Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation","volume":"3","author":"Motwani","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2023.176047_bib83","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2023.176047_bib84","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/ATVBAHA.112.249508","article-title":"Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions","volume":"32","author":"Norling","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2023.176047_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax4895","article-title":"Resolution metabolomes activated by hypoxic environment","volume":"5","author":"Norris","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2023.176047_bib86","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.2147\/IJGM.S357460","article-title":"Potential of omega 3 supplementation for coronavirus disease 2019 (COVID-19): a scoping review","volume":"15","author":"Nursyifa Fadiyah","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib87","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.4049\/jimmunol.1103652","article-title":"Resolvin E2 formation and impact in inflammation resolution","volume":"188","author":"Oh","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256226","article-title":"Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients","volume":"16","author":"Palmas","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176047_bib89","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1172\/JCI127282","article-title":"Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases","volume":"129","author":"Panigrahy","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.176047_bib90","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1111\/bph.15212","article-title":"Formyl peptide receptor type 2 agonists to kick-start resolution pharmacology","volume":"177","author":"Perretti","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176047_bib91","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1038\/s41598-020-61390-8","article-title":"Novel RvD6 stereoisomer induces corneal nerve regeneration and wound healing post-injury by modulating trigeminal transcriptomic signature","volume":"10","author":"Pham","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2023.176047_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92293-x","article-title":"ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea","volume":"11","author":"Pham","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2023.176047_bib93","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.1073\/pnas.1921335117","article-title":"Resolvin E1 is a pro-repair molecule that promotes intestinal epithelial wound healing","volume":"117","author":"Quiros","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.176047_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076145","article-title":"Intra-airway treatment with synthetic lipoxin A4 and resolvin E2 mitigates neonatal asthma triggered by maternal exposure to environmental particles","volume":"24","author":"Ramar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.176047_bib95","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fphar.2019.00252","article-title":"Roles, actions, and therapeutic potential of specialized pro-resolving lipid mediators for the treatment of inflammation in cystic fibrosis","volume":"10","author":"Recchiuti","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176047_bib96","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001952R","article-title":"Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages","volume":"35","author":"Recchiuti","year":"2021","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2023.176047_bib97","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1183\/09031936.00106013","article-title":"Reduced 15-lipoxygenase 2 and lipoxin A4\/leukotriene B4 ratio in children with cystic fibrosis","volume":"44","author":"Ringholz","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2023.176047_bib98","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jcf.2017.11.017","article-title":"Resolvin D1 regulates epithelial ion transport and inflammation in cystic fibrosis airways","volume":"17","author":"Ringholz","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejphar.2023.176047_bib99","article-title":"First total synthesis of the pro-resolving lipid mediator 7(S),12(R),13(S)-resolvin T2 and its 13(R)-epimer","volume":"61","author":"Rodriguez","year":"2020","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejphar.2023.176047_bib100","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.4049\/jimmunol.1101665","article-title":"Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses","volume":"189","author":"Rogerio","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.584206","article-title":"Resolvins: potent pain inhibiting lipid mediators via transient receptor potential regulation","volume":"8","author":"Roh","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2023.176047_bib102","doi-asserted-by":"crossref","first-page":"12750","DOI":"10.1096\/fj.201900283R","article-title":"Resolvin E3 attenuates allergic airway inflammation via the interleukin-23-interleukin-17A pathway","volume":"33","author":"Sato","year":"2019","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2023.176047_bib103","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/s41467-018-05800-6","article-title":"Resolution of chronic inflammatory disease: universal and tissue-specific concepts","volume":"9","author":"Schett","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2023.176047_bib104","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.4049\/jimmunol.1501701","article-title":"Resolvin D1 polarizes primary human macrophages toward a proresolution phenotype through GPR32","volume":"196","author":"Schmid","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib105","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.176047_bib106","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4049\/jimmunol.0901809","article-title":"The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury","volume":"184","author":"Seki","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib107","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.176047_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2017.03.001","article-title":"Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology","volume":"58","author":"Serhan","year":"2017","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib109","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.176047_bib110","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib111","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib112","doi-asserted-by":"crossref","first-page":"a016311","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejphar.2023.176047_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101597","article-title":"E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition","volume":"59","author":"Serhan","year":"2022","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib114","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJM199407283310403","article-title":"Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. atherosclerosis risk in communities study investigators","volume":"331","author":"Shahar","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115078","article-title":"Resolvin E1 attenuates doxorubicin-induced endothelial senescence by modulating NLRP3 inflammasome activation","volume":"201","author":"Shamoon","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176047_bib116","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100053R","article-title":"Resolvin E3 ameliorates high-fat diet-induced insulin resistance via the phosphatidylinositol-3-kinase\/Akt signaling pathway in adipocytes","volume":"36","author":"Shimizu","year":"2022","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2023.176047_bib117","doi-asserted-by":"crossref","first-page":"L746","DOI":"10.1152\/ajplung.00166.2014","article-title":"Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1","volume":"307","author":"Shinohara","year":"2014","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2023.176047_bib118","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.176047_bib119","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/bcp.13149","article-title":"Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2\/ALX agonist ACT-389949","volume":"83","author":"Stalder","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176047_bib120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2016.00160","article-title":"Resolution of inflammation: what controls its onset?","volume":"7","author":"Sugimoto","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib121","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.it.2019.01.007","article-title":"Mediators of the resolution of the inflammatory response","volume":"40","author":"Sugimoto","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib122","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.20170681","article-title":"Resolvins suppress tumor growth and enhance cancer therapy","volume":"215","author":"Sulciner","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib123","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/npr2.12198","article-title":"Resolvin D2 attenuates chronic pain-induced depression-like behavior in mice","volume":"41","author":"Suzuki","year":"2021","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.ejphar.2023.176047_bib124","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2165\/00003495-197816030-00006","article-title":"Corticosteroids: clinical pharmacology and therapeutic use","volume":"16","author":"Swartz","year":"1978","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2023.176047_bib125","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2023.176047_bib126","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.4049\/jimmunol.1100225","article-title":"Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype","volume":"187","author":"Titos","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib127","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.chembiol.2006.09.011","article-title":"Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis","volume":"13","author":"Tjonahen","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejphar.2023.176047_bib128","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaci.2018.06.008","article-title":"Paucigranulocytic asthma: uncoupling of airway obstruction from inflammation","volume":"143","author":"Tliba","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib129","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd1453","article-title":"Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution","volume":"7","author":"Trilleaud","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2023.176047_bib130","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2169\/internalmedicine.48.1741","article-title":"Acute lung injury review","volume":"48","author":"Tsushima","year":"2009","journal-title":"Intern. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib131","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.plipres.2010.09.002","article-title":"Resolvins: natural agonists for resolution of pulmonary inflammation","volume":"50","author":"Uddin","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ejphar.2023.176047_bib132","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.biomaterials.2015.02.120","article-title":"Development of an immunomodulatory biomaterial: using resolvin D1 to modulate inflammation","volume":"53","author":"Vasconcelos","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejphar.2023.176047_bib133","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.semarthrit.2008.08.001","article-title":"Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention","volume":"39","author":"Vonkeman","year":"2010","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2023.176047_bib134","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pupt.2011.04.001","article-title":"Resolvin D1 protects mice from LPS-induced acute lung injury","volume":"24","author":"Wang","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2023.176047_bib135","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.4049\/jimmunol.1302421","article-title":"Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na,K-ATPase via ALX\/cAMP\/PI3K pathway in lipopolysaccharide-induced acute lung injury","volume":"192","author":"Wang","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.176047_bib136","doi-asserted-by":"crossref","DOI":"10.1038\/srep18972","article-title":"Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance","volume":"6","author":"Winkler","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ejphar.2023.176047_bib137","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/JLB.3MI0617-254R","article-title":"Structural insights into Resolvin D4 actions and further metabolites via a new total organic synthesis and validation","volume":"103","author":"Winkler","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2023.176047_bib138","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2133.2012.11177.x","article-title":"Efficacy and safety of 15(R\/S)-methyl-lipoxin A(4) in topical treatment of infantile eczema","volume":"168","author":"Wu","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejphar.2023.176047_bib139","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nm.2123","article-title":"Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions","volume":"16","author":"Xu","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2023.176047_bib140","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96530-1","article-title":"Effect of resolvin D5 on T cell differentiation and osteoclastogenesis analyzed by lipid mediator profiling in the experimental arthritis","volume":"11","author":"Yamada","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2023.176047_bib141","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/srep03113","article-title":"Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birth","volume":"3","author":"Yamashita","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2023.176047_bib142","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2018.07.016","article-title":"Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma","volume":"139","author":"Ye","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2023.176047_bib143","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/labinvest.2017.114","article-title":"ResolvinD1 stimulates epithelial wound repair and inhibits TGF-\u03b2-induced EMT whilst reducing fibroproliferation and collagen production","volume":"98","author":"Zheng","year":"2018","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2023.176047_bib144","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1007\/s10753-018-0819-2","article-title":"Resolvin D1 promotes SIRT1 expression to counteract the activation of STAT3 and NF-\u03baB in mice with septic-associated lung injury","volume":"41","author":"Zhuo","year":"2018","journal-title":"Inflammation"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923005599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923005599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:21:54Z","timestamp":1757978514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923005599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":144,"alternative-id":["S0014299923005599"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176047","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic potential of resolvins in pulmonary diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176047"}}